Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.07 - Immunology and Immunotherapy

    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • Presentations: 48
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.07-010 - Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

      09:30 - 09:30  |  Presenter: Junko Tanizaki

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA 05 - Next Generation TKI

    • Type: Oral
    • Track: Advanced NSCLC
    • Presentations: 9
    • +

      OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations

      16:05 - 16:15  |  Presenter: Keunchil Park

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03 - Chemotherapy/Targeted Therapy

    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 59
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.03-008 - Phase I/II Study of Intermitted Erlotinib in Combination with Docetaxel in Patients with Recurrent NSCLC with Wild-Type EGFR: WJOG 4708L

      09:30 - 09:30  |  Presenter: Tatsuo Kimura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P2.03-045 - Updated Results of Phase II, Liquid Biopsy Study in EGFR Mutated NSCLC Patients Treated with Afatinib (WJOG 8114LTR)

      09:30 - 09:30  |  Presenter: Hidetoshi Hayashi

      • Abstract

      Loading...

    • +

      P2.03-058a - T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive NSCLC

      09:30 - 09:30  |  Presenter: Takeshi Yoshida

      • Abstract
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.07 - Immunology and Immunotherapy

    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • Presentations: 65
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.07-021 - A Checkpoint Molecule B7-H3 as a Novel Immune Therapy Target for Non-Small Cell Lung Cancer (NSCLC)

      09:30 - 09:30  |  Presenter: Kimio Yonesaka

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.